ArticleCardiovascular diabetology2023

Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetes.

Tomoka Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.